Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity

Aim. To assess the antihypertensive effectiveness of perindopril and enalapril, as well as their effects on metabolic parameters, in patients with arterial hypertension (AH) and obesity (O). Material and methods. This blind, randomized, controlled, parallel comparative study included 60 patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Nedogoda, A. A. Ledyaeva, E. V. Chumachok, V. V. Tsoma, G. G. Mazina, A. S. Salasyuk, I. N. Barykina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1988
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850041485667336192
author S. V. Nedogoda
A. A. Ledyaeva
E. V. Chumachok
V. V. Tsoma
G. G. Mazina
A. S. Salasyuk
I. N. Barykina
author_facet S. V. Nedogoda
A. A. Ledyaeva
E. V. Chumachok
V. V. Tsoma
G. G. Mazina
A. S. Salasyuk
I. N. Barykina
author_sort S. V. Nedogoda
collection DOAJ
description Aim. To assess the antihypertensive effectiveness of perindopril and enalapril, as well as their effects on metabolic parameters, in patients with arterial hypertension (AH) and obesity (O). Material and methods. This blind, randomized, controlled, parallel comparative study included 60 patients with AH and O, who were administered perindopril or enalapril for 24 weeks. Results. Perindopril demonstrated significantly better antihypertensive effectiveness, cardio-, angio-, and nephroprotection, as well as an improvement in lipid, carbohydrate, and purine metabolism parameters. In patients with AH and O, only perindopril had beneficial effects on insulin resistance, hyperleptinemia, and inflammation. In contrast to enalapril treatment, perindopril therapy was associated with a marked improvement in anthropometry parameters and a reduction in fat tissue deposits. Conclusion. In patients with a combination of AH and O, perindopril was superior to enalapril in terms of antihypertensive effectiveness, organ protection, and the effects on key humoral factors determining body mass increase and blood pressure elevation.
format Article
id doaj-art-1883da7e49d8474b968f0010f97e9d03
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 1970-01-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-1883da7e49d8474b968f0010f97e9d032025-08-20T02:55:46Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-0110710171700Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesityS. V. Nedogoda0A. A. Ledyaeva1E. V. Chumachok2V. V. Tsoma3G. G. Mazina4A. S. Salasyuk5I. N. Barykina6Volgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityAim. To assess the antihypertensive effectiveness of perindopril and enalapril, as well as their effects on metabolic parameters, in patients with arterial hypertension (AH) and obesity (O). Material and methods. This blind, randomized, controlled, parallel comparative study included 60 patients with AH and O, who were administered perindopril or enalapril for 24 weeks. Results. Perindopril demonstrated significantly better antihypertensive effectiveness, cardio-, angio-, and nephroprotection, as well as an improvement in lipid, carbohydrate, and purine metabolism parameters. In patients with AH and O, only perindopril had beneficial effects on insulin resistance, hyperleptinemia, and inflammation. In contrast to enalapril treatment, perindopril therapy was associated with a marked improvement in anthropometry parameters and a reduction in fat tissue deposits. Conclusion. In patients with a combination of AH and O, perindopril was superior to enalapril in terms of antihypertensive effectiveness, organ protection, and the effects on key humoral factors determining body mass increase and blood pressure elevation.https://cardiovascular.elpub.ru/jour/article/view/1988arterial hypertensionobesityperindoprilenalapril
spellingShingle S. V. Nedogoda
A. A. Ledyaeva
E. V. Chumachok
V. V. Tsoma
G. G. Mazina
A. S. Salasyuk
I. N. Barykina
Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
Кардиоваскулярная терапия и профилактика
arterial hypertension
obesity
perindopril
enalapril
title Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
title_full Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
title_fullStr Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
title_full_unstemmed Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
title_short Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
title_sort comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
topic arterial hypertension
obesity
perindopril
enalapril
url https://cardiovascular.elpub.ru/jour/article/view/1988
work_keys_str_mv AT svnedogoda comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT aaledyaeva comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT evchumachok comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT vvtsoma comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT ggmazina comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT assalasyuk comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity
AT inbarykina comparativeeffectivenessofperindoprilandenalaprilinpatientswitharterialhypertensionandobesity